Denali Therapeutics Inc (DNLI)
17.14
0.00 (0.00%)
USD |
NASDAQ |
May 06, 11:58
Denali Therapeutics Stock Buybacks (Quarterly)
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | -420.15M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | -193.95M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -94.41M |
| December 31, 2017 | -265.62M |
| September 30, 2017 | 0.00 |
| June 30, 2017 | |
| March 31, 2017 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-420.15M
Minimum
Sep 2020
--
Maximum
Jun 2019
-87.73M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 252.30M |
| AIM ImmunoTech Inc | -0.147M |
| Perspective Therapeutics Inc | -0.364M |
| Protalix BioTherapeutics Inc | 0.00 |
| Armata Pharmaceuticals Inc | 0.00 |